HC

Investor profile

Henry Clark

Venture capital

A venture capital investor based in Raleigh, North Carolina, United States, Henry Clark has 5 known investments: Decisiv, Inc., Protochips, Reliable Biopharmaceutical, LLC, Rieke Metals, LLC and Thrive 4-7.

Is Henry Clark a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Stage
Growth

Contacts

hcl***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Henry Clark portfolio companies (5)

  • Decisiv, Inc.
  • Protochips
  • Reliable Biopharmaceutical, LLC
  • Rieke Metals, LLC
  • Thrive 4-7

Investor Profile

The listing covers sectors Hardware, Healthcare and SaaS, and focus areas Advanced Materials, Biopharma, Digital Health and Enterprise Software. Startups operating in these areas may find Henry Clark relevant.

Stage-wise, the known deals cluster around Growth rounds.

Reviewing the investment history helps decide whether there is a realistic fit before reaching out.

Similar investors

Showing 20 of 98

PD

Paul Davidson

venture capital investor

McLean, United States

Venture capital
CW

Curt Witte

venture capital investor

Dorado, Puerto Rico

Venture capital
RC

Robert Corbett

venture capital investor

New York City, United States

Venture capital
MR

Michael Rees

venture capital investor

New York, United States

Venture capital
AH

Andrew Hopping

venture capital investor

Austin, United States

Venture capital
DB

Dan Brooks

angel investor

San Francisco, United States

Angel
TW

Theo Woik

venture capital investor

Frankfurt, Germany

Venture capital
BH

Blayke Hale

venture capital investor

Venture capital
MG

Mark Gormley

venture capital investor

New York, United States

Venture capital
MS

Matt Shofner

venture capital investor

Dallas, United States

Venture capital
MS

Matt Scott

venture capital investor

New York, United States

Venture capital
DB

David Browne

venture capital investor

Sydney, Australia

Venture capital
OL

Oded Levy

venture capital investor

New York, United States

Venture capital
MB

Matt Bell

venture capital investor

Taylors, United States

Venture capital
RP

Rupa Popat

venture capital investor

London, United Kingdom

Venture capital
DS

Daniel Sundheim

venture capital investor

Miami, United States

Venture capital
PC

Peter Christodoulo

venture capital investor

San Francisco, United States

Venture capital
JC

James Coulter

venture capital investor

New York, United States

Venture capital
CA

Cooper Ainge

venture capital investor

Salt Lake City, United States

Venture capital
DB

Dave Brown

venture capital investor

Jackson, United States

Venture capital
+78moreAvailable after registration

Frequently asked questions

Who is Henry Clark?

Henry Clark is a venture capital investor based in Raleigh, North Carolina, United States with 5 known investments on file, among them Decisiv, Inc., Protochips and Reliable Biopharmaceutical, LLC. The sections above list the sectors and stages attached to that record.

What does Henry Clark invest in?

Listed sectors include Hardware, Healthcare and SaaS; listed focus areas include Advanced Materials, Biopharma, Digital Health and Enterprise Software. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Henry Clark invest at?

The known deals of Henry Clark include Growth rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

How do I contact Henry Clark?

An email address, a phone number and a LinkedIn page are on file for Henry Clark. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal